REG - Avingtrans PLC - Trading Update and Notice of Results

AvingtransAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260121:nRSU6485Pa&default-theme=true

RNS Number : 6485P  Avingtrans PLC  21 January 2026

21 January 2026

 

Avingtrans plc

 

("Avingtrans", the "Company", or the "Group")

 

Trading Update and Notice of Results

 

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical
components, modules, systems and associated services to the energy, medical
and industrial sectors, announces that trading in the first six months of the
financial year to 30 November 2025 was in line with management expectations.

 

CEO, Steve McQuillan commented: "We are pleased to note the positive momentum
continuing across the Group, particularly for those group businesses that are
supplying products into AI and Data Centre driven markets, as well as the
associated resurgence in nuclear power, albeit that the main growth effects of
these tailwinds will not be seen until FY27 and beyond. The recently announced
tie-up between TerraPower and Meta is exciting for next generation nuclear
prospects.

 

"We are also delighted to welcome Stuart Gall as CEO of the Medical and
Industrial Imaging division earlier than expected. Stuart's appointment
provides us with a seasoned head to look afresh at the strategies and
development plans for Adaptix and Magnetica, as we seek to bring innovative
medical imaging at the point of care to global markets.

 

"We remain confident in our ability to meet market expectations for FY26 and
this reflects our ongoing commitment to delivering value and achieving our
strategic objectives. The opportunity pipeline remains buoyant and the Group
is in positive discussions with a number of new and existing customers
regarding contracts that are likely to commence in FY27."

 

Notice of Results

 

Avingtrans will publish its results for the six months ended 30 November 2025
on 25 February 2026, at which time it will provide a further performance
update.

 

The Company's management will be hosting a virtual presentation for analysts
on the day of results at 9.30 a.m. BST. Those who wish to attend the briefing
should register their interest with Zach Cohen at
zach.cohen@investor-focus.co.uk (mailto:zach.cohen@investor-focus.co.uk) .

 

Enquiries:

 

 Avingtrans plc                                          01354 692 391
 Roger McDowell, Chairman

 Steve McQuillan, Chief Executive Officer

 Stephen King, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)   020 7496 3000
 Sara Hale

 Alex Bond

 IFC Advisory (Financial PR)                             020 3934 6630
 Graham Herring

 Tim Metcalfe

 Zach Cohen

 

About Avingtrans plc:

 

Avingtrans designs, manufactures and supplies original equipment, systems and
associated aftermarket services to the energy, medical and industrial markets
worldwide.

 

Business units

 

 Hayward Tyler - Luton, East Kilbride UK, USA, China and India

 Specialises in the design, manufacture and servicing of performance-critical
 motors and pumps for challenging environments.

 Energy Steel, Inc - Rochester Hills, Michigan, USA

 Provider of custom fabrications for the nuclear industry, specialising in: OEM
 parts obsolescence; custom fabrications; engineering design solutions; product
 refurbishment; on-site technical support.

 Stainless Metalcraft Ltd - Chatteris, UK

 Provider of safety-critical equipment for the energy, medical, science and
 research communities, worldwide, specialising in precision pressure and vacuum
 vessels and associated fabrications, sub-assemblies and systems.

 Booth Industries - Bolton, UK

 Designs, manufactures, installs and services doors and walls which can be
 tailored to be: blast and explosion proof; fireproof; acoustically shielded;
 high security/safety; or combinations of the above.

 Ormandy Group - Bradford, UK

 Design, manufacturers and servicing of off-site plant, heat exchangers and
 other HVAC (heating, ventilation and air conditioning) products.

 Slack & Parr - Kegworth, UK, USA & China

 Design, manufacture and servicing of high-precision gear metering pumps,
 hydraulics flow dividers and industrial pumps.

 Composite Products Ltd - Buckingham, UK

 Centre for composite technology, parts and assemblies, serving customers in
 industrial markets.

 Adaptix Ltd - Oxford, UK

 Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary
 applications amongst others. Commercialisation of this system (and others) is
 on-going.

 Magnetica Ltd - Brisbane, Australia

 Magnetica Limited specialises in the development of next generation MRI
 technologies, including dedicated extremity MRI systems and MRI system
 components. Magnetica has successfully built and tested a compact, integrated
 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging.
 Commercialisation of this system (and others) is on-going. Magnetica's
 structure now includes two other business units:

 Scientific Magnetics - Abingdon, UK

 Designs and manufactures superconducting magnet systems and associated
 cryogenics for a variety of markets including MRI and provides services for
 Nuclear Magnetic Resonance instruments.

 Tecmag Inc - Houston, USA

 Designs, manufactures and installs instrumentation, including consoles, system
 upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear
 Magnetic Resonance (NMR) systems.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTBMMFTMTTTBAF



            Copyright 2019 Regulatory News Service, all rights reserved